Biohaven Therapeutics Ltd.
Clinical trials sponsored by Biohaven Therapeutics Ltd., explained in plain language.
-
Drug trial for severe seizures halted early
Disease control TerminatedThis study aimed to test if adding the experimental drug BHV-7000 to a person's current anti-seizure medications could help control severe generalized tonic-clonic seizures in adults with a specific type of epilepsy. The trial was designed to compare the drug to a placebo over 24…
Phase: PHASE2, PHASE3 • Sponsor: Biohaven Therapeutics Ltd. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Safety check for bipolar drug halted
Disease control TerminatedThis study aimed to check the long-term safety and side effects of an investigational drug called BHV-7000 for adults with bipolar I disorder. It was an extension study for 94 people who had already completed a previous short-term trial. The main goal was to monitor for any serio…
Phase: PHASE2 • Sponsor: Biohaven Therapeutics Ltd. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC